Rifat Pamukcu insider trades

Open-market stock purchases and sales by Rifat Pamukcu, Director at Aprea Therapeutics, Inc, from SEC Form 4 filings since Jul 28, 2022.

Recent trades

DateStockTradeValue
Jun 16, 2026APRE Aprea Therapeutics, IncBought (not open market)—
Jun 16, 2026APRE Aprea Therapeutics, IncBought (not open market)—

Companies traded

  • APRE Aprea Therapeutics, Inc: other filings, last Jun 16, 2026

Get free alerts when Rifat Pamukcu files a new trade →